Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion.
AffiliationTransplantation Laboratory, Manchester Royal Infirmary, Manchester, UK. email@example.com
MetadataShow full item record
AbstractAcute graft versus host disease (aGvHD) is a major cause of early morbidity post-haematopoietic stem cell transplantation with minor histocompatibility antigens being a contributing factor. One mHA encoded by the UDP glycosyltransferase 2 family polypeptide B17 (UGT2B17) gene has been shown to be immunogenic because of differential expression in the donor and recipient. We investigated the effects of a homozygous gene deletion of UGT2B17 on the severity of acute aGvHD post-HSCT in HLA-matched related donors. 115 donor and recipient HLA and UGT2B17 genotypes were determined using PCR-SSO and PCR-SSP, respectively. aGvHD grading was determined using routine criteria and dichotomized into either nonclinically significant (0-I) or clinically significant (II-IV). For all analyses, P-values of ≤ 0.05 were considered significant. The frequency of the gene deletion within the total cohort tested was 29.1%. A significant increase in aGvHD severity (grades II-IV) was seen in UGT2B17 recipients expressing the protein when transplanted with a UGT2B17 disparate donor (P = 0.011). We observed a significant association between UGT2B17 expressing recipients and UGT2B17 deficient donors with the severity of aGvHD. This study provides additional evidence that genomic variations may predispose to more severe aGvHD, but are not a mechanism for GvHD.
CitationIncreased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion. 2013, 40 (2):116-9 Int J Immunogenet
JournalInternational Journal of Immunogenetics
- A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.
- Authors: Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Riddell SR, Morishima Y, Kodera Y, Naoe T
- Issue date: 2005 Apr
- A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
- Authors: Terakura S, Murata M, Warren EH, Sette A, Sidney J, Naoe T, Riddell SR
- Issue date: 2007 May 15
- UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation.
- Authors: Santos N, Rodríguez-Romanos R, Nieto JB, Buño I, Vallejo C, Jiménez-Velasco A, Brunet S, Buces E, López-Jiménez J, González M, Ferrá C, Sampol A, de la Cámara R, Martínez C, Gallardo D, GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH).
- Issue date: 2016 Jan
- Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
- Authors: Sellami MH, Bani M, Torjemane L, Kaabi H, Ladeb S, Ben Othmane T, Hmida S
- Issue date: 2011 Feb
- Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
- Authors: Goyal RK, Lin Y, Schultz KR, Ferrell RE, Kim Y, Fairfull L, Livote E, Yanik G, Atlas M
- Issue date: 2010 Jul